Axa
VSTM icon

Axa’s Verastem VSTM Stock Holding History

Axa’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,950
Closed -$69K – 1367
2019
Q1 		$69K Buy
+1,950
New +$77K ﹤0.01% 1301
2018
Q3 		– Sell
-1,975
Closed -$163K – 1391
2018
Q2 		$163K Sell
1,975
-4,560
-70% -$279K ﹤0.01% 1316
2018
Q1 		$234K Hold
6,535
– – ﹤0.01% 1299
2017
Q4 		$241K Buy
6,535
+1,593
+32% +$71.9K ﹤0.01% 1284
2017
Q3 		$279K Buy
+4,942
New +$233K ﹤0.01% 1215
2015
Q3 		– Sell
-65,220
Closed -$5.9M – 1521
2015
Q2 		$5.9M Buy
65,220
+14,072
+28% +$1.49M 0.02% 552
2015
Q1 		$6.24M Buy
+51,148
New +$5.36M 0.03% 528

Other funds holding VSTM

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Axa's VSTM Position: Q2 2019 in Review

Axa sold out of Verastem (VSTM) in Q2 2019, closing a stake of 1,950 shares — an estimated $69K sold.

Axa first reported a position in VSTM in Q1 2015 and held it in 7 quarters. The position peaked at $6.24M in Q1 2015. 94 funds tracked by Wall St. Rank hold VSTM as of Q2 2019.

  • Axa reported no remaining Verastem position as of Q2 2019 after selling out during the quarter.
  • Axa sold 1,950 Verastem shares in Q2 2019, an estimated $69K.
  • Axa first reported a position in Verastem in Q1 2015 and held it in 7 quarters.
  • Axa's Verastem position peaked at $6.24M in Q1 2015.
  • 94 funds tracked by Wall St. Rank held Verastem as of Q2 2019.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.